Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors-Reference-Cited by-同舟云学术

Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors

Published:2016-04 Issue:4 Volume:26 Page:169-177
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Nelveg-Kristensen Karl E.,Madsen Majbritt B.,Torp-Pedersen Christian,Køber Lars,Egfjord Martin,Hansen Torben,Pedersen Oluf,Rasmussen Henrik B.,Hansen Peter R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference48 articles.

1. . A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.;Kober;N Engl J Med,1995

2. . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.;Pfeffer;N Engl J Med,1992

3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.;Lancet,1993

4. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.;Webb;Lancet,2010

5. Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects.;Elliott;Clin Pharmacol Ther,1996

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Identification of Key Genes and Biological Pathways in Cardiac Arrest by Integrated Bioinformatics and Next Generation Sequencing Data Analysis;2024-08-19

2. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

3. Pharmacogenetic study of CES1 gene and enalapril efficacy;Journal of Applied Genetics;2024-01-23

4. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators;Drug Metabolism and Disposition;2019-12-23

5. Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure;The Pharmacogenomics Journal;2019-01-17